EPRX Bathi mangsa ngarep Eupraxia Pharmaceuticals Inc.

Simbol resmi perusahaan Eupraxia Pharmaceuticals, Inc. (EPRX)

The absence of sales due to the testing stage leaves Eupraxia Pharmaceuticals (EPRX) dependent on capital, which is confirmed by the trend in projected profits. The value of 0.00 expresses the metric's value today. Regulatory barriers and logistical disruptions during international registration amplify the risks. However, control over microsphere technology while outsourcing production protects the startup from supplier dependency.

Eupraxia Pharmaceuticals (EPRX): Bathi resik sing dikarepake saka 06.04.2024 nganti 06.04.2024

Eupraxia Pharmaceuticals, Inc. - rincian analitis lan metrik utama (EPRX)

- rega saham lan konsensus proyeksi valuasi:
Analisis fundamental perusahaan:EPRX, Eupraxia Pharmaceuticals, Inc.
Produk dadi Eupraxia Pharmaceuticals Inc.

Investors are verifying the issuer's resilience through multiples, comparing the current share price with the potential for cash flow generation. The trend in analyst earnings expectations reflects a recalculation of net income accounting for liquidity risks, which for Eupraxia Pharmaceuticals (EPRX) depends directly on the success of clinical trials for long-acting drugs and the effectiveness of capital raising to scale the business.

Analisis pesaing Eupraxia Pharmaceuticals

Bathi mangsa ngarep HLN|Proyeksi bathi mangsa ngarep Kenvue Corp|Bathi mangsa ngarep VRNA (Verona Pharma Corp)|MENS (Jyong Bio) - Penghasilan resik sing dikarepake|Bathi sing dikarepake Ligand Pharmaceuticals Incorporated LGND|Amneal (AMRX) - Bathi resik sing dikarepake|PRGO: Bathi mangsa ngarep|Alvotech SA - Bathi resik mangsa ngarep|LQDA: Proyeksi bathi mangsa ngarep|Galapagos Genomics - Penghasilan resik sing dikarepake|ANIP (ANI Pharmaceuticals Inc) - Proyeksi bathi mangsa ngarep|Bathi resik sing dikarepake mannkindcorp.com MNKD|Bathi sing dikarepake Amphastar Pharmaceuticals, Inc. (AMPH)|PCRX (Pacira Pharmaceuticals) - Penghasilan resik sing dikarepake|Proyeksi bathi mangsa ngarep SPRY (ARS Pharmaceuticals Inc)|Bathi resik mangsa ngarep TBPH (Theravance)|AQST - Bathi sing dikarepake|scPharmaceuticals (SCPH) - Bathi mangsa ngarep|TECX: Proyeksi bathi mangsa ngarep|Prakiraan bathi resik TNXP|Bathi sing dikarepake China SXT Pharmaceuticals, Inc.|BHST: Penghasilan resik sing dikarepake|Bathi mangsa ngarep EXOZ (Invizyne Technologies)|ORMP - Bathi resik sing dikarepake|Proyeksi bathi mangsa ngarep ENTX (Entera Bio Ltd)|Proyeksi bathi mangsa ngarep MindWalk Holdings, Inc. HYFT|ABVC BioPharma, Inc - Proyeksi bathi mangsa ngarep|CPIX: Bathi sing dikarepake|QNTM (Quantum BioPharma Ltd) - Bathi mangsa ngarep|Prakiraan bathi resik FGEN|Bathi sing dikarepake Telomir Pharmaceuticals|RANI: Penghasilan resik sing dikarepake|Proyeksi bathi mangsa ngarep SNYR|Bathi mangsa ngarep Rallybio Corp RLYB|Bathi sing dikarepake Lexaria Bioscience Corp. LEXX|Prakiraan bathi perusahaan pulmatrix.com (PULM)|Pheton Holdings Limited - Proyeksi bathi mangsa ngarep|Bathi forward APM|LYRA (Lyra Therapeutics Inc.) - Bathi mangsa ngarep|IBO - Prakiraan bathi perusahaan|Bathi mangsa ngarep TNFA|Prakiraan bathi resik YCBD (cbdmd.com)|Bathi mangsa ngarep PRFX (PainReform Ltd)|CYTO: Bathi forward|Proyeksi bathi mangsa ngarep LIPO (lipella.com)|Bathi resik mangsa ngarep OPTN (OptiNose Corp)|PIRS: Bathi mangsa ngarep|PROC - Proyeksi bathi mangsa ngarep|PTPI: Proyeksi bathi mangsa ngarep|Qilian International Holding Group (QLI) - Proyeksi bathi mangsa ngarep|SLRN (ACELYRIN, Inc.) - Proyeksi bathi mangsa ngarep|TFF Pharmaceuticals (TFFP) - Prakiraan bathi perusahaan